'Intensive palliative care': a qualitative study of issues related to nurses' care of people with amyotrophic lateral sclerosis at end-of-life

S Daneau, A Bourbonnais, É Allard… - Palliative care and …, 2023 - journals.sagepub.com
Background: Amyotrophic lateral sclerosis (ALS) is currently an incurable and fatal disease,
which often comes with a high symptom burden at the end-of-life stage. Little is known about …

'Intensive palliative care': a qualitative study of issues related to nurses' care of people with amyotrophic lateral sclerosis at end-of-life

S Daneau, A Bourbonnais, É Allard… - Palliative care and …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Amyotrophic lateral sclerosis (ALS) is currently an incurable and fatal disease,
which often comes with a high symptom burden at the end-of-life stage. Little is known about …

[HTML][HTML] 'Intensive palliative care': a qualitative study of issues related to nurses' care of people with amyotrophic lateral sclerosis at end-of-life

S Daneau, A Bourbonnais, É Allard, M Asri… - Palliative Care and …, 2023 - ncbi.nlm.nih.gov
Background: Amyotrophic lateral sclerosis (ALS) is currently an incurable and fatal disease,
which often comes with a high symptom burden at the end-of-life stage. Little is known about …

'Intensive palliative care': a qualitative study of issues related to nurses' care of people with amyotrophic lateral sclerosis at end-of-life.

S Daneau, A Bourbonnais, É Allard… - Palliative Care & …, 2023 - search.ebscohost.com
Background: Amyotrophic lateral sclerosis (ALS) is currently an incurable and fatal disease,
which often comes with a high symptom burden at the end-of-life stage. Little is known about …

'Intensive palliative care': a qualitative study of issues related to nurses' care of people with amyotrophic lateral sclerosis at end-of-life.

S Daneau, A Bourbonnais, É Allard, M Asri… - Palliative Care and …, 2023 - europepmc.org
Background Amyotrophic lateral sclerosis (ALS) is currently an incurable and fatal disease,
which often comes with a high symptom burden at the end-of-life stage. Little is known about …